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Abstract: The thus-far unknown ureic derivative dimethyl 2,2′-[carbonylbis(azanediyl)](2S,2′S)
-bis[3-(4-hydroxyphenyl)propanoate] has been efficiently synthesized by enantiospecific oxidative
carbonylation of readily available L-tyrosine methyl ester, using a very simple catalytic system (PdI2
in conjunction with KI) under relatively mild conditions (100 ◦C for 5 h in DME as the solvent and
under 20 atm of a 4:1 mixture CO-air).
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1. Introduction
Ureas are very important carbonyl compounds. Many ureic derivatives have shown interesting
biological activities, including anticancer activity [1,2]. Moreover, they find different practical
applications, including their use as gelators or hydrogen-bond donors [3,4].
A very attractive method for the preparation of ureas is based on direct carbonylation of amines
under oxidative conditions [5,6]. In this field, we have previously reported that a very simple catalytic
system, consisting of PdI2 in conjunction with KI, is able to promote the oxidative carbonylation of
primary amines to symmetrically 1,2-disubstituted ureas as well as of primary and secondary amines
to trisubstituted ureas with excellent selectivities (up to 99%) and very high turnover numbers (up to
43,500 mmol of urea per mmol of palladium) [7–9].
In this Short Note, we report the application of our method to the enantiospecific synthesis of
the previously unknown 2′-[carbonylbis(azanediyl)](2S,2′S)-bis[3-(4-hydroxyphenyl)propanoate] 2
starting from commercially available L-tyrosine methyl ester, according to Scheme 1.
2. Results
2′-[Carbonylbis(azanediyl)](2S,2'S)-bis[3-(4-hydroxyphenyl)propanoate] 2 was prepared by
enantiospecific palladium-catalyzed oxidative carbonylation of commercially available L-tyrosine
methyl ester 1, under the following reaction conditions (Scheme 1): PdI2, 1 mol %; KI, 10 mol %;
solvent, 1,2-dimethoxyethane (DME; substrate concentration: 1 mmol per mL of DME); T = 100 ◦C;
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P = 20 atm (at 25 ◦C) of a 4:1 mixture of CO-air. The desired product was obtained in 95% isolated
yield after 5 h reaction time and purification of the crude mixture by column chromatography on silica
gel (eluent: hexane-AcOEt from 1:1 to 4:6), and was fully characterized by LC-MS spectrometry, IR,
1H-NMR and 13C spectroscopies, elemental analysis, and specific optical rotation.
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Scheme  1.  Enantiospecific  synthesis  of  2′‐[carbonylbis(azanediyl)](2S,2′S)‐bis[3‐(4‐
hydroxyphenyl)propanoate]  2  by  PdI2/KI‐catalyzed  oxidative  carbonylation  of  commercially 
available L‐tyrosine methyl ester 1. 
2. Results 
2′‐[Carbonylbis(azanediyl)](2S,2ʹS)‐bis[3‐(4‐hydroxyphenyl)propanoate]  2  was  prepared  by 
enantiospecific palladium‐catalyzed  oxidative  carbonylation  of  commercially  available  L‐tyrosine 

















Italia  s.r.l., Milano,  Italy). Column  chromatography was performed on  silica gel 60  (Merck  s.p.a., 
Vimodrone, Milano, Italy, 70−230 mesh). Evaporation refers to the removal of solvent under reduced 
pressure. Melting point is uncorrected. 1H‐NMR and 13C‐NMR spectra were recorded at 25 °C on a 
300 MHz  spectrometer  (Bruker DPX Avance  300,  Bruker  Italia  s.r.l., Milano,  Italy)  in DMSO‐d6 
solutions with Me4Si as the internal standard. Chemical shifts (δ) and coupling constants (J) are given 
in ppm and Hz, respectively. IR spectrum was taken with a JASCO FTIR 4200 spectrometer. Mass 
spectrum  was  obtained  using  a  HPLC/ESI/Q‐TOF  HRMS  apparatus.  HPLC  conditions  were  as 
follows: water,  acetonitrile,  and  formic  acid were  of HPLC/MS  grade;  the HPLC  system was  an 
Agilent 1260 Infinity; a reversed‐phase C18 column (ZORBAX Extended‐C18 2.1 × 50 mm, 1.8 m) 
with a Phenomenex C18 security guard column  (4 mm × 3 mm) were used;  the  flow‐rate was 0.4 
mL/min and the column temperature was set to 30 °C; the eluents were formic acid–water (0.1:99.9, 
Scheme 1. Enantiospecific synthesis of 2′-[carbonylbis(azanediyl)](2S,2′S)-bis[3-(4-hydroxyphenyl)propanoate]
2 by PdI2/KI-catalyzed oxidative carbonylation of commercially available L-tyrosine methyl ester 1.
According to our previous findings, the formation of urea 2 can be inte preted as occurring as
shown in Scheme 2, involving the formation of a carbamoylpalladium iodide intermediate I (by the
reaction between the amino group of the s bstrate, CO, a d PdI2) foll wed by β-H elimination from
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Italia  s.r.l., Milano,  Italy). Column chromatography was performed on  silica gel 60  (Merck  s.p.a., 
Vimodrone, Milano, Italy, 70−230 mesh). Evaporation refers to the removal of solvent under reduced 
pressure. Melting point is uncorrected. 1H‐NMR and 13C‐NMR spectra were recorded at 25 °C on a 
300 MHz  spectrometer  (Bruker DPX Avance  300,  Br k r  Italia  s.r.l., Milano,  Italy)  in DMSO‐d6
solutio s with Me4Si as the internal s and rd. Chemical shifts (δ) and coupling con tants (J) are given
in ppm and Hz, respectively. IR spectrum was taken with a JASCO FTIR 4200 sp ctrometer. Mass
spectrum  was  obtained  using  a  HPLC/ESI/Q‐TOF  HRMS  apparatus.  HPLC  conditions  were  s
follows: water,  cetonitrile,  and  formic  acid were  of HPLC/MS  grade;  the HPLC  system was  an
Agilent 1260 Infinity; a reversed‐phase C18 colum  (ZORBAX Extended‐C18 2.1 × 50 mm, 1.8 m)
with a Phenomenex C18 security guard column  (4 mm × 3 mm) were used;  the  flow‐rate was 0.4
mL/mi  and the column t mp ature was set to 30 °C; the eluents were formi  acid–water (0.1:99.9,
Scheme 2. Proposed mechanism for the formation of urea 2 from L-tyrosine methyl ester 1.
3. Materials and Methods
Solvents and chemicals were reagent grade and used without further purification. Reactions were
analyzed by thin layer chromatography (TLC) on silica gel 60 F254 (Merck s.p.a., Vimodrone, Milano,
Italy). Starting material L-tyrosine methyl ester was commercially available (Sigma-Aldrich Italia s.r.l.,
Milano, Italy). Column chromatography was performed on silica gel 60 (Merck s.p.a., Vimodrone,
Milano, Italy, 70−230 mesh). Ev poration r fer to he removal of solvent under educed pressure.
Melting point is uncorrected. 1H-NMR and 13C-NMR spectra were recorded at 25 ◦C on a 300 MHz
spectrometer (B uker DPX Av nce 300, Bruker Italia s.r.l., Mila o, Italy) in DMSO-d6 solutions with
Me4Si as the internal standard. Chemical shifts (δ) and coupling constants (J) are given in ppm and
Hz, respectively. IR spectrum was taken with a JASCO FTIR 4200 spectrometer. Mass spectrum was
obtained using a HPLC/ESI/Q-TOF HRMS apparatus. HPLC conditions were as follows: water,
acetonitrile, and formic acid were of HPLC/MS grade; the HPLC system was an Agilent 1260 Infinity;
a reversed-phase C18 column (ZORBAX Extended-C18 2.1 × 50 mm, 1.8 µm) with Phenomenex C18
security guard column (4 mm × 3 mm) were used; the flow-rate was 0.4 mL/min and the column
temperature was set to 30 ◦C; the eluents were formic acid–water (0.1:99.9, v/v) (phase A) and formic
acid–acetonitrile (0.1:99.9, v/v) (phase B); the following gradient was employed: 0–10 min, linear
gradient from 5% to 95% B; 10–15 min, washing and reconditioning of the column to 5% B; injection
volume was 10 µL; the eluate was monitored through MS TIC. The mass spectra was recorded using an
Agilent 6540 UHD accurate-mass Q-TOF spectrometer equipped with a Dual AJS ESI source working
in negative mode, under the following conditions: N2 was employed as desolvation gas at 300 ◦C
and a flow rate of 9 L/min; the nebulizer was set to 45 psig; the sheath gas temperature was set
at 400 ◦C and a flow of 12 L/min; a potential of 2.7 kV was used on the capillary for positive ion
mode; the fragmentor was set to 175 V; the MS spectrum was recorded in the 150–1000 m/z range.
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Microanalysis was carried out in our analytical laboratory (Thermo–Fischer Elemental Analyzer Flash
2000, Rodano, Milano, Italy).
Synthetic procedure for the preparation of 2′-[carbonylbis(azanediyl)](2S,2′S)-bis[3
-(4-hydroxyphenyl)propanoate] 2. A 250 mL stainless steel autoclave was charged in the presence
of air with PdI2 (8.2mg, 0.023 mmol), KI (36.5 mg, 0.22 mmol), and a solution of L-tyrosine methyl
ester 1 (433.6 mg, 2.22 mmol) in DME (2.2 mL). While stirring, the autoclave was pressurized with CO
(16 atm) and air (up to 20 atm) and then heated at 100 ◦C for 5 h. After cooling, the autoclave was
degassed and solvent evaporated. Some amount of crude product was already present in suspension
in the reaction mixture. Crude urea 2 was further purified by column chromatography on silica gel
using hexane/ethyl acetate from 1/1 to 4/6 as eluent. Yield: 439.3 mg, 95% based on starting 1.
Pure 2′-[carbonylbis(azanediyl)](2S,2′S)-bis[3-(4-hydroxyphenyl)propanoate] 2 was a pale yellow
solid, m.p. = 89–91 ◦C. [α]22D (acetone, c = 6.51 × 10−3 g·mL−1) = +215.1◦; IR (KBr): ν = 3389 (m, br),
1728 (s), 1651 (w), 1557 (m), 1514 (m), 1443 (m), 1368 (w), 1219 (s), 1115 (w), 841 (w), 802 (m) cm–1;
1H-NMR (300 MHz, DMSO-d6): δ = 9.29 (s, 2H, 2 OH), 6.97–6.90 (m, 4H, aromatic), 6.71–6.63 (m, 4H,
aromatic), 6.44 (d, J = 7.9, 2H, 2 NH), 4.34–4.23 (m, 2H, 2 CHCH2), 3.58 (s, 6H, 2 CO2Me), 2.89–2.70
(m, 4H, 2 CHCH2); 13C-NMR (75 MHz, DMSO-d6): δ = 172.8, 156.6, 156.0, 130.0, 126.7, 115.0, 54.2,
51.6, 36.6; LC-MS: m/z = 415 [(M − H)–]; anal. calcd for C21H24N2O7 (416.43): C, 60.88; H, 6.10; N,
6.87; found: C, 60.86; H, 6.13; N, 6.85. Copies of the 1H-NMR and 13C-NMR spectra are given in the
Supplementary Materials.
Supplementary Materials: 1H-NMR and 13C-NMR spectra for product 2 are available online at www.mdpi.com/
1422-8599/2018/1/M983/s1.
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